←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, Clinical Leadership
Richard Champlin
MD
🏢MD Anderson Cancer Center🌐USA
Chair, Department of Stem Cell Transplantation and Cellular Therapy
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Richard Champlin chairs stem cell transplantation at MD Anderson and has led landmark trials of reduced intensity conditioning and donor lymphocyte infusion. He pioneered clinical programs that now form the global HCT standard. He has mentored many transplant leaders.
Share:
🧪Research Fields 研究领域
allogeneic HCT
reduced intensity conditioning
cell therapy
leukemia transplant
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Richard Champlin 的研究动态
Follow Richard Champlin's research updates
留下邮箱，当我们发布与 Richard Champlin（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment